Patents by Inventor Michael Edward Flaugh

Michael Edward Flaugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht receptor
    Patent number: 7230011
    Abstract: The present invention relates to compounds of formula I: which are antagonists of 5-HT6 receptor.
    Type: Grant
    Filed: January 17, 2002
    Date of Patent: June 12, 2007
    Assignee: Eli Lilly and Company
    Inventors: Sandra Ann Filla, Michael Edward Flaugh, James Ronald Gillig, Lawrence Joseph Heinz, Joseph Herman Krushinski, Jr., Bin Liu, Marta Maria Pineiro-Nunez, John Mehnert Schaus, John Stanley Ward
  • Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
    Publication number: 20040102481
    Abstract: The present invention relates to compounds of formula I: which are antagonists of 5-HT6 receptor.
    Type: Application
    Filed: July 22, 2003
    Publication date: May 27, 2004
    Inventors: Sandra Ann Filla, Michael Edward Flaugh, James Ronald Gillig, Lawrence Joseph Heinz, Joseph Herman Krushinski, Bin Liu, Marta Maria Pineiro-Nunez, John Mehnert Schaus, John Stanley Ward
  • Carboxamides useful as 5-HT1F agonists
    Patent number: 6221884
    Abstract: The present invention provides novel 2-amino-1,2,3,4-tetrahydro-9H-carbazole-6-carboxamides and 3-amino-10H-cyclohepta[7,6-b]indole-7-carboxamides of Formula I: where R1, R2, R3 and n are as described in the specification.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: April 24, 2001
    Assignee: Eli Lilly and Company
    Inventor: Michael Edward Flaugh
  • Preparation of 4-halo and 6-halomelatonins
    Patent number: 6022980
    Abstract: This invention provides an improved process for the preparation and separation of 4-halo and 6-halomelatonins.
    Type: Grant
    Filed: May 13, 1999
    Date of Patent: February 8, 2000
    Assignee: Eli Lilly and Company
    Inventor: Michael Edward Flaugh
  • Pharmaceutical method using 6-substituted-1, 2, 3, 4-tetrahydro-9H-carbazoles and 7-substituted-10H -cyclohepta (7, 6-B) indoles
    Patent number: 5814653
    Abstract: This invention provides novel 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta?7,6-b!indoles. These compounds are 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders.
    Type: Grant
    Filed: December 17, 1997
    Date of Patent: September 29, 1998
    Assignee: Eli Lilly and Company
    Inventors: Michael Edward Flaugh, Anton Daniel Kiefer, Jr., Clint Duane Walker, Yao-Chang Xu
  • 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta ?7,6-B!indoles: New 5-HT.sub.1F agonists
    Patent number: 5708187
    Abstract: This invention provides novel 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta?7,6-b!indoles. These compounds are 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders.
    Type: Grant
    Filed: June 27, 1996
    Date of Patent: January 13, 1998
    Assignee: Eli Lilly and Company
    Inventors: Michael Edward Flaugh, Anton Daniel Kiefer, Jr., Clint Duane Walker, Yao-Chang Xu